LaQuitaMarieJonesDO
Pediatric Hematology & Oncology • Cincinnati, OHPediatric Hematologic Oncology
Cincinnati Children's Cancer & Blood Institute
Dr. Jones is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Avenue
Cincinnati, OH 45229Phone+1 513-636-4200
Summary
- Dr. LaQuita Jones is a pediatric oncologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. At Cincinnati Children's, she is a physician-scientist and member of the leukemia/lymphoma team. She received her medical degree from Ohio University Heritage College of Osteopathic Medicine in Athens, residency at Nationwide Children's, and fellowship at Cincinnati Children's. She has been in practice 6 years. She specializes in pediatric hematologic oncology. She has 15 publications and her laboratory has been grant funded since 2017.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2018
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2012 - 2015
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 2012
Certifications & Licensure
OH State License 2012 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- K08 National Cancer Institute, 2023-2027
- V Scholar V Foundation, 2022-2024
- St. Baldrick's Scholar St. Baldrick's Foundation, 2021-2024
- Join now to see all
Publications & Presentations
PubMed
- Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia.Scott B Hoyt, Chris J Finocchio, Elizabeth Croll, Gregory J Tawa, Huixu Li
ACS Medicinal Chemistry Letters. 2024-11-14 - Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukae...Francis R LeBlanc, Erin H Breese, Karen C Burns, Ellen K Chang, LaQuita M Jones
British Journal of Haematology. 2024-09-01 - 1 citationsIKAROS and MENIN in synergy in AML.LaQuita M Jones, Daniel T Starczynowski
Nature Cancer. 2022-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
